Patents by Inventor James A. Johnston

James A. Johnston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120266375
    Abstract: An emergency shower system attaches to a water pipe behind a wall and a valve mounted to the pipe. A frame is mounted to the wall around the valve, and a panel connected to the frame for covering an opening in the wall. The panel has an opening, and a plate is mounted to the panel to close the panel opening. A handle is mounted to the plate. A linkage is pivotally connected to the plate and to the valve. Vertical movement of the handle and plate are translated to rotational movement by the linkage to operate the valve. The handle only moves vertically at a constant distance from the wall. An eye/face wash station may be included. The eye/face wash station includes a pull down tray with spray nozzles. The nozzles are connected to another valve which is opened by the rotation of the pull down tray.
    Type: Application
    Filed: April 23, 2012
    Publication date: October 25, 2012
    Applicant: ENCON SAFETY PRODUCTS, INC.
    Inventors: James Ellis Marrs, Robert James Johnston
  • Publication number: 20120239396
    Abstract: A method and system for operating a remotely controlled device may use multimodal remote control commands that include a gesture command and a speech command. The gesture command may be interpreted from a gesture performed by a user, while the speech command may be interpreted from speech utterances made by the user. The gesture and speech utterances may be simultaneously received by the remotely controlled device in response to displaying a user interface configured to receive multimodal commands.
    Type: Application
    Filed: March 15, 2011
    Publication date: September 20, 2012
    Applicant: AT&T INTELLECTUAL PROPERTY I, L.P.
    Inventors: Michael James Johnston, Marcelo Worsley
  • Patent number: 8073125
    Abstract: Audio in an audio conference is spatialized using either virtual sound-source positioning or sound-field capture. A spatial audio conference is provided between a local and remote parties using audio conferencing devices (ACDs) interconnected by a network. Each ACD captures spatial audio information from the local party, generates either one, or three or more, audio data streams which include the captured information, and transmits the generated stream(s) to each remote party. Each ACD also receives the generated audio data stream(s) transmitted from each of the remote parties, processes the received streams to generate a plurality of audio signals, and renders the signals to produce a sound-field that is perceived by the local party, where the sound-field includes the spatial audio information captured from the remote parties. A sound-field capture device is also provided which includes at least three directional microphones symmetrically configured about a center axis in a semicircular array.
    Type: Grant
    Filed: September 25, 2007
    Date of Patent: December 6, 2011
    Assignee: Microsoft Corporation
    Inventors: Zhengyou Zhang, James Johnston
  • Publication number: 20110217244
    Abstract: The use of oxidatively transformed carotenoid or a component thereof to enhance the immune response in a subject for the treatment of infection or to enhance the immune response to an antigen in a subject being immunized. Also disclosed are pharmaceutical compositions and kits containing the oxidatively transformed carotenoid.
    Type: Application
    Filed: October 23, 2008
    Publication date: September 8, 2011
    Applicant: National Research Council of Canada
    Inventors: James Johnston, Bozena Korczak, Graham Burton
  • Publication number: 20110177526
    Abstract: An isolated polynucleotide encodes JAK-3 protein. JAK-3 protein is a protein tyrosine kinase having a molecular weight of approximately 125 kDa which has tandem non-identical catalytic domains, lacks SH2 or SH3 domains, and is expressed in NK cells and stimulated or transformed T cells, but not in resting T cells. The protein itself and antibodies to this protein are also presented. Further, methods of identifying therapeutic agents for modulating the immune system make use of the foregoing.
    Type: Application
    Filed: March 4, 2011
    Publication date: July 21, 2011
    Applicant: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT., OF HEALTH & HUMAN SERVICES
    Inventors: John J. O'Shea, Warren J. Leonard, James A. Johnston, Sarah M. Russell, Daniel W. McVicar, Masaru Kawamura
  • Publication number: 20110150886
    Abstract: Described are cross-specific antibody molecules with binding specificity for both AREG and HBEGF. The antibody molecules may be used in methods of treatment of cancer and diseases associated with angiogenesis.
    Type: Application
    Filed: April 17, 2009
    Publication date: June 23, 2011
    Applicant: FUSION ANTIBODIES LIMITED
    Inventors: Jill Caswell, Shane Olwill, James Johnston, Richard Buick, Thomas Jaquin, Declan Doherty, Christopher Scott
  • Patent number: 7902348
    Abstract: An isolated polynucleotide encodes JAK-3 protein. JAK-3 protein is a protein tyrosine kinase having a molecular weight of approximately 125 kDa which has tandem non-identical catalytic domains, lacks SH2 or SH3 domains, and is expressed in NK cells and stimulated or transformed T cells, but not in resting T cells. The protein itself and antibodies to this protein are also presented. Further, methods of identifying therapeutic agents for modulating the immune system make use of the foregoing.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: March 8, 2011
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: John J. O'Shea, Warren J. Leonard, James A. Johnston, Sarah M. Russell, Daniel W. McVicar, Masaru Kawamura
  • Patent number: 7890249
    Abstract: According to one embodiment of the disclosure, a method of determining a center of gravity of an aircraft includes receiving a strut length for each of the gears of an aircraft, determining an arm length for each of the gears, and determining a center of gravity of the aircraft based on a relationship between the center of gravity and respective arm lengths for each of the gears. The arm length of each of the gears is determined according to the strut length of a gear strut of a respective gear and a relationship between the strut length of the gear strut to another gear of another aircraft and the arm length of the respective gear.
    Type: Grant
    Filed: July 3, 2008
    Date of Patent: February 15, 2011
    Assignee: Nordic Industries, Inc.
    Inventors: Dick E. Davis, James R. Emmons, Amith M. Kalaghatagi, George R. Lindberg, James A. Johnston
  • Publication number: 20110020404
    Abstract: The invention relates to methods for diagnosis of tuberculosis in an animal, the methods comprising determining the presence or absence of, or an immune response to a group of antigens comprising (i) the group consisting of Rv3616 antigen, MPB70 antigen, MPB83 antigen, and ESAT 6 antigen; or (ii) at least seven of the antigens of the group consisting of Rv3616 antigen, MPB70 antigen, MPB83 antigen, ESAT 6 antigen, CFP10 antigen, ? crystalline 2 antigen, PE35 antigen, and PPE68 antigen. Also provided is a method for the diagnosis of the presence of tuberculosis in a reservoir animal e.g. a badger, said method comprising determining the presence or absence of, or an immune response to Rv3616 antigen, MPB70 antigen, and MPB83 antigen. Kits for carrying out the methods are also provided.
    Type: Application
    Filed: August 18, 2008
    Publication date: January 27, 2011
    Applicants: FUSION ANTIBODIES LIMITED, ENFER TECHNOLOGY LIMITED
    Inventors: Shane A. Olwill, James A. Johnston, Hang Fai Kwok, Clare Whelan, John Clarke
  • Patent number: 7835904
    Abstract: The perceptual scalable audio coding/decoding technique lies in the use of a psychoacoustic mask to guide residue coding in enhancement layer coders. At the encoder, a psychoacoustic mask is calculated for the enhancement layer coders or is simply extracted from the coded base layer bitstream. One can also decode the coded base layer bitstream into the audio waveform, and calculate the psychoacoustic mask from the decoded base layer waveform. Furthermore, a predictive technology can be used to refine the psychoacoustic mask derived from the base layer bitstream to form a more accurate psychoacoustic mask of the enhancement layer. In addition, one can calculate the enhancement layer psychoacoustic mask from the original audio, and send the difference between the enhancement layer psychoacoustic mask and the base layer psychoacoustic mask as side information to the decoder. This psychoacoustic mask may then be used for the perceptual coding and decoding of the residue.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: November 16, 2010
    Assignee: Microsoft Corp.
    Inventors: Jin Li, James Johnston, Wai Yip Chan
  • Patent number: 7748976
    Abstract: A burner-based exhaust gas generation system, for producing exhaust gas, typically for use in testing exhaust system devices. Post-burner exhaust gas is recirculated back to a main exhaust line, and used for purposes such as cooling or enhancing the burner output.
    Type: Grant
    Filed: March 16, 2006
    Date of Patent: July 6, 2010
    Assignee: Southwest Research Institute
    Inventors: Robert Wayne Burrahm, Michael Glenn Ross, Cynthia Chaffin Webb, Suzanne Annette Timmons, Gordon James Johnston Bartley
  • Patent number: 7741127
    Abstract: A method of using a burner-based system to produce diesel exhaust gas that contains particulate matter of a desired composition, to simulate the PM matter in exhaust produced by a production-type diesel internal combustion engine.
    Type: Grant
    Filed: June 20, 2007
    Date of Patent: June 22, 2010
    Assignee: Southwest Research Institute
    Inventors: Gordon James Johnston Bartley, Cynthia Chaffin Webb, Imad Abdul-Khalek
  • Publication number: 20100111965
    Abstract: The invention provides a method of treating neoplastic disease in a subject, said method comprising the simultaneous, sequential or separate, administration to said subject of an effective amount of (i) an inhibitor of a first EGF, e.g. HB-EGF and (ii) an inhibitor of a second EGF, e.g. AREG. Also described are novel synergistic combinations of EGF inhibitors with topoisomerase inhibitors which attenuate tumour cell growth. Further described are novel anti AREG antibodies.
    Type: Application
    Filed: October 11, 2007
    Publication date: May 6, 2010
    Applicant: FUSION ANTIBODIES LIMITED
    Inventors: James Johnston, Shane Olwill, Jill Brown, Nuala Morgan, Thomas Jaquin, Christopher Scott
  • Publication number: 20100086551
    Abstract: A method of inhibiting angiogenesis in a group of cells, a tissue or an organ includes administering an antibody molecule or nucleic acid encoding an antibody molecule to the cells, tissue or organ, wherein the antibody molecule specifically binds cathepsin S, but does not inhibit proteolytic activity of cathepsin S.
    Type: Application
    Filed: October 12, 2007
    Publication date: April 8, 2010
    Applicant: Fusion Antibodies Limited
    Inventors: Shane Olwill, Christopher Scott, James Johnston, Roberta Burden
  • Patent number: 7689921
    Abstract: A method and system for displaying information related to a plurality of resources in a network environment. The system uses web technology to receive and store information related to back-end resources and to provide a framework by which client computer systems can manage the plurality of back-end resources in a uniform manner. In accordance with one method, a request is received to display object information from different network resources. In response, attribute and task information is retrieved from the appropriate different network resources and this information is displayed. A graphical user interface (GUI) displays information related to network resource objects. The GUI includes a console displaying a tool zone and a work zone. A module is displayed in the work zone having an object zone displaying a list of objects and a task zone displaying a list of tasks.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: March 30, 2010
    Assignee: Microsoft Corporation
    Inventors: Vij Rajarajan, Kishnan Nedungadi, Brijesh Bhatia, Casey Kiernan, Anandha Ganesan, James Johnston, Lauren Gallagher, Kevin Hodge, Tom Martino, Cary Rohwer, Andrew Hayes, Annette B. Hall, Audrius Zimnicks, Mel MacMahon
  • Publication number: 20100008963
    Abstract: The present invention provides a delivery device for use in the control of a target animal species, the delivery device including: (a) a core containing a control agent for the target animal species, and (b) an impermeable coating enclosing the core, the coating being selected to provide exposure of the core in the gastrointestinal tract of the target animal species; wherein the coating of the delivery device has a hardness such that the coating is not readily breached upon mastication by a target or non-target animal species and further wherein the delivery device will not pass through a Tyler 5 mesh.
    Type: Application
    Filed: July 10, 2009
    Publication date: January 14, 2010
    Applicant: Commonwealth of Australia as represented by & acting through the Dept. of Environment Water....
    Inventors: Michael O'Donoghue, James Alan Morris, Michael James Johnston, Michael James Lindeman
  • Publication number: 20090269360
    Abstract: The invention relates to a method of inhibiting chemotherapy induced upregulation of Cathepsin S on the surface of tumour cells, the method comprising the administration of a Cathepsin S inhibitor to said cells. Also provided is a therapy comprising an anti Cathepsin S antibody, in particular an anti-Cathepsin S antibody which does not inhibit the proteolytic effect of Cathepsin S but nevertheless inhibits angiogenesis and a combination treatment comprising a Cathepsin S inhibitor and a therapeutic agent.
    Type: Application
    Filed: April 10, 2007
    Publication date: October 29, 2009
    Applicant: Fusion Antibodies Limited
    Inventors: Shane Olwill, Christopher Scott, Julie Gormley, Jaquin Thomas, Roberta Burden, Darragh McMeel, James Johnston
  • Publication number: 20090243693
    Abstract: A high voltage analog interface circuit capable of producing a determinate zero or other low voltage when the high voltage power supply is turned off or grounded.
    Type: Application
    Filed: March 31, 2008
    Publication date: October 1, 2009
    Inventors: Meetul GOYAL, Robert James Johnston, Romesh Trivedi
  • Publication number: 20090208446
    Abstract: Described is a method of modulating the activation of a Rho, Arf, Rab, Ran or Rap family protein, said method comprising administering to said sample a USP-17 modulator, for example an inhibitor of expression or activity of DUB-3. The invention enables the use of USP-17 modulators in the treatment of metastatic cancer and other conditions.
    Type: Application
    Filed: May 14, 2007
    Publication date: August 20, 2009
    Applicant: THE QUEEN'S UNIVERSITY OF BELFAST
    Inventors: James Johnston, James Burrows, Alyson Kelvin
  • Publication number: 20090137787
    Abstract: An isolated polynucleotide encodes JAK-3 protein. JAK-3 protein is a protein tyrosine kinase having a molecular weight of approximately 125 kDa which has tandem non-identical catalytic domains, lacks SH2 or SH3 domains, and is expressed in NK cells and stimulated or transformed T cells, but not in resting T cells. The protein itself and antibodies to this protein are also presented. Further, methods of identifying therapeutic agents for modulating the immune system make use of the foregoing.
    Type: Application
    Filed: January 15, 2009
    Publication date: May 28, 2009
    Applicant: GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEA
    Inventors: John J. O'Shea, Warren J. Leonard, James A. Johnston, Sarah M. Russell, Daniel W. McVicar, Masaru Kawamura